The Sustain Switch trial compares the effect and safety of 2 different dose schedules for semaglutide (study medicine) in people with type 2 diabetes previously treated with a diabetes medicine similar to semaglutide.
The Libre Pro trial is a 15 day trial for safety and efficacy of the Libre Flash 14 day system.
Semaglutide Cardiovascular Outcomes Trial in Patients With Type 2 Diabetes.
A 52-week study that compares the efficacy of Relamorelin with that of placebo in participants with diabetic gastroparesis with respect to the core signs and symptoms of diabetic gastroparesis.
This study will assess how well empagliflozin and linagliptin work in children and adolescents(DINAMO).
Seeking pediatric Type 1 subjects to assess accuracy and reliability of a new-to-market flash glucose monitoring system (Libre Flash).
Fill out the form below an we will let you know when a study becomes available that you may be interested in:
